Needham analyst Serge Belanger downgraded Kalvista Pharmaceuticals Inc (NASDAQ: KALV) from Buy to Hold.

For an analyst ratings summary and ratings history on Kalvista Pharmaceuticals Inc click here. For more ratings news on Kalvista Pharmaceuticals Inc click here.

Shares of Kalvista Pharmaceuticals Inc closed at $26.67 yesterday.